Ticker Details
Sarepta Therapeutics, Inc. Sarepta Therapeutics Inc is a biotechnology company. It uses proprietary RNA-targeted technology platforms for developing pharmaceutical products to address serious diseases.
IPO Date:	July 12, 2012
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.98B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.52 | 2.46%
Avg Daily Range (30 D):	$0.62 | 2.99%
Avg Daily Range (90 D):	$0.62 | 3.08%

Institutional Daily Volume
Avg Daily Volume:	1.83M
Avg Daily Volume (30 D):	2.3M
Avg Daily Volume (90 D):	3.22M

Trade Size
Avg Trade Size (Sh.):	107
Avg Trade Size (Sh.) (30 D):	70
Avg Trade Size (Sh.) (90 D):	80

Institutional Trades
Total Institutional Trades:	13,823
Avg Institutional Trade:	$4.05M
Avg Institutional Trade (30 D):	$3.33M
Avg Institutional Trade (90 D):	$3.61M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$8.77M
Avg Closing Trade (30 D):	$6.19M
Avg Closing Trade (90 D):	$8.18M
Avg Closing Volume:	124.2K

News

Jan 26, 2026 @ 1:41 PM Stock Market Today: Dow Futures Gain, S&P 500 Slip... Source: Rishabh Mishra

Jan 22, 2026 @ 3:30 AM 2 Beaten-Down Stocks That Could Sink Even More in ... Source: Prosper Junior Bakiny

Dec 24, 2025 @ 2:14 PM Silver Breaks Above $70, Novo Nordisk Soars 9% On ... Source: Piero Cingari

Nov 4, 2025 @ 5:11 PM Sarepta Stock Dumps: Pharma Bro Martin Shkreli Sti... Source: Erica Kollmann

Oct 7, 2025 @ 3:00 PM AAV Gene Therapy Market Size to Skyrocket at 40.1%... Source: Towards Healthcare

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-2.7	$-1.8	$2.01
Diluted EPS	$-2.81	$-1.8	$1.89
Revenue	$2.41B	$399.36M	$611.09M
Gross Profit
Net Income / Loss	$-271.51M	$-179.95M	$196.89M
Operating Income / Loss	$-126.52M	$-103.39M	$115.58M
Cost of Revenue
Net Cash Flow	$412.77M	$100.03M	$269.73M
PE Ratio

Splits
Jul 12, 2012	1:6